KMap
Dr. Watts is co-director of the University of Arizona Cancer Center (UACC) Genomics Shared Service supported by the UACC and the Southwest Environmental Health Sciences Center. He has 20 years of molecular biology experience with emphasis on analysis of nucleic acids including their isolation and quality control, sequencing, expression, and data analysis.

VOSviewer

Courses
  • PACD
    Pharmacology of Anti-Cancer Drugs

  • CHP
    Comprehensive Human Pharmacology

  • IDP
    Infectious Disease Pharmacology

Grants
  • Funding agency logo
    I-Corps: Rapid Home Microbiome Diagnostics Tests

    Co-Investigator (COI)

    2020

    $50.0K
    Active
  • Funding agency logo
    Southwest Environmental Health Sciences Center

    Co-Investigator (COI)

    2018

    $7.3M
    Active
  • Funding agency logo
    Improving the Diagnosis of Febrile Neutropenia in Hematopoeitic Stem Cell Transplant Patients

    Principal Investigator (PI)

    2016

    $74.9K
  • Funding agency logo
    Southwest Environmental Health Sciences Center

    Co-Investigator (COI)

    2012

    $8.3M
  • Funding agency logo
    Arizona Cancer Center - Cancer Center Support Grant

    Co-Investigator (COI)

    2009

    $27.1M
  • Funding agency logo
    Arizona Cancer Center - Cancer Center Support Grant (NON Supplement)

    Co-Investigator (COI)

    2009

    $61.4K
  • Funding agency logo
    Southwest Environmental Health Sciences Center

    Co-Investigator (COI)

    2006

    $7.8M
Technologies / Patents
      News
      • Researcher Uses 'Shotgun Sequencing' to Study Microorganisms

        2018

      • UA Employees Have Strong '40 Under 40' Showing

        2009

      • Campus Scientists to Explore Biomedical Research

        2005

      Publications (44)
      Recent
      • Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease

        2022

      • An adaptable and non-invasive method for tracking Bifidobacterium animalis subspecies lactis 420 in the mouse gut

        2021

      • Metagenomic Next-Generation Sequencing in Clinical Microbiology

        2020

      • Speed, accuracy, sensitivity and quality control choices for detecting clinically relevant microbes in whole blood from patients

        2019

      • Paraneoplastic Leukemoid Reaction Associated with Increased Levels of and Tumor Overexpression of Receptors for G-CSF, GM-CSF, and IL-6: A Clinico-Pathological-Molecular Study

        2018

      • 16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria

        2017

      • Characterization of a novel radiation-induced sarcoma cell line.

        2015

      • Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6

        2015

      • Innovative qPCR using interfacial effects to enable low threshold cycle detection and inhibition relief

        2015

      • Abstract 1200: Characterization of a novel radiation-induced sarcoma cell line

        2014

      • Environmental arsenic exposure and microbiota in induced sputum

        2014

      • Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations

        2014

      • Three-dimensional printing surgical instruments: are we there yet?

        2014

      • Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes

        2013

      • The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration

        2012

      • Abstract 1641: Concordance between mutations identified by bar-coded multiplexed sequencing of BRAF, NRAS, and KIT in formalin fixed (FFPE) tissue from melanoma patients using the Ion Torrent Personal Genome Machine (PGM) and a real-time PCR assay

        2012

      • The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid

        2012

      • A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus

        2010

      • S1626 A Novel Mechanism of Bile Acid Induced Damage: Relevance to Esophageal Carcinogenesis

        2010

      • Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma

        2009

      • Agglomerative epigenetic aberrations are a common event in human breast cancer

        2008

      • M1957 Expression of Bile Acid Transporting Proteins in Barrett s Esophagus and Esophageal Adenocarcinoma

        2008

      • DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage

        2008

      • Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells

        2008

      • Profiling of selenomethionine responsive genes in colon cancer by microarray analysis

        2007

      • Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma

        2007

      • Large-scale regulatory network analysis from microarray data: modified Bayesian network learning and association rule mining

        2007

      • Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161

        2006

      • AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells

        2006

      • Epigenetic inactivation of the HOXA gene cluster in breast cancer

        2006

      • The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells

        2004

      • The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.

        2004

      • Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations

        2004

      • Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression

        2003

      • Low-level arsenite induced gene expression in HEK293 cells

        2003

      • Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate

        2002

      • Laminin-5-mediated gene expression in human prostate carcinoma cells

        2001

      • Microarray analysis of a human multiple myeloma cell line selected with melphalan or doxorubicin identifies a set of commonly affected genes

        2001

      • Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis.

        2001

      • cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways

        2001

      • Implementing microarrays for the study of plant genomics

        1999

      • Gene expression profiles associated with MDR1 expression in a doxorubicin-resistant human multiple myeloma cell line

        1999

      • Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene

        1997

      • Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion

        1995

      Grants
      Citations
      H-Index
      Patents
      News
      Books
      Opportunities